Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Shares of Sarepta Therapeutics Inc. (SRPT) traded 20% higher on Tuesday afternoon after the U.S. Food and Drug Administration ...

That's because there has been a string of negative developments over the past several months, including three deaths from liver failure of patients taking Sarepta's DMD drugs - which led to a pause in ...

Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...

Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors ...